Join Growin Stock Community!

Personalis, inc.PSNL.US Overview

US StockHealthcare
(No presentation for PSNL)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

PSNL AI Insights

PSNL Overall Performance

PSNL AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

PSNL Recent Performance

-8.28%

Personalis, inc.

-3.61%

Avg of Sector

-2.16%

S&P500

PSNL PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

PSNL Key Information

PSNL Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

PSNL Profile

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.

Price of PSNL

PSNL FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

PSNL Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.92
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
11.55
PB Ratio
4.67
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
22.65%
Net Margin
-116.69%
Revenue Growth (YoY)
-17.69%
Profit Growth (YoY)
-41.19%
3-Year Revenue Growth
1.23%
3-Year Profit Growth
-6.33%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.92
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
11.55
PB Ratio
4.67
Price-to-FCF
-
Gross Margin
22.65%
Net Margin
-116.69%
Revenue Growth (YoY)
-17.69%
Profit Growth (YoY)
-41.19%
3-Year Revenue Growth
1.23%
3-Year Profit Growth
-6.33%
  • When is PSNL's latest earnings report released?

    The most recent financial report for Personalis, inc. (PSNL) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating PSNL's short-term business performance and financial health. For the latest updates on PSNL's earnings releases, visit this page regularly.

  • What is the operating profit of PSNL?

    According to the latest financial report, Personalis, inc. (PSNL) reported an Operating Profit of -25.27M with an Operating Margin of -145.67% this period, representing a decline of 39.5% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is PSNL's revenue growth?

    In the latest financial report, Personalis, inc. (PSNL) announced revenue of 17.35M, with a Year-Over-Year growth rate of 3.24%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does PSNL have?

    At the end of the period, Personalis, inc. (PSNL) held Total Cash and Cash Equivalents of 124.25M, accounting for 0.37 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does PSNL go with three margins increasing?

    In the latest report, Personalis, inc. (PSNL) did not achieve the “three margins increasing” benchmark, with a gross margin of 11%%, operating margin of -145.67%%, and net margin of -137.3%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess PSNL's profit trajectory and future growth potential.

  • Is PSNL's EPS continuing to grow?

    According to the past four quarterly reports, Personalis, inc. (PSNL)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.26. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of PSNL?

    Personalis, inc. (PSNL)'s Free Cash Flow (FCF) for the period is -22.32M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 146.94% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of PSNL?

    The latest valuation data shows Personalis, inc. (PSNL) has a Price-To-Earnings (PE) ratio of -11.63 and a Price/Earnings-To-Growth (PEG) ratio of -0.93. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.